Behçet's syndrome: one year in review 2022
Gülen Hatemi, Emire Seyahi, İzzet Fresko, Rosaria Talarico, Didar Uçar, Vedat Hamuryudan
Abstract
This review highlights publications on different aspects of Behçet's syndrome (BS) that appeared in 2021 and provides a critical view. These publications include works on the epidemiology of BS across different continents, newly developed instruments to assess damage in BS, studies highlighting the immunopathogenesis, genetics and epigenetic factors, histopathology of the pathergy lesion, clinical and imaging aspects of vascular involvement, and safety and efficacy of therapeutic agents including tocilizumab, apremilast and direct oral anticoagulants.
Topics & Concepts
MedicineTocilizumabDermatologyEpidemiologyApremilastVasculitisIntensive care medicinePathologyImmunologyPsoriasisPsoriatic arthritisRheumatoid arthritisDiseaseOcular Diseases and Behçet’s SyndromeRetinal and Optic ConditionsVasculitis and related conditions